Colonization Resistance: Battle of the Bugs or Ménage à Trois with the Host?

1. LawleyTD, WalkerAW (2013) Intestinal colonization resistance. Immunology 138: 1–11.

2. BohnhoffM, DrakeBL, MillerCP (1954) Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proc Soc Exp Biol Med 86: 132–137.

3. SaitoK (1961) Studies on the habitation of pathogenic Escherichia coli in the intestinal tract of mice. I. Comparative experiments on the habitation of each type of resistant pathogenic Escherichia coli under an administration of streptomycin. Paediatria Japonica 65: 385–393.

4. SaitoK (1961) Studies on the habitation of pathogenic Escherichia coli in the intestinal tract of mice. II. Experimental inoculation of type 055 Escherichia coli after long-term administration of streptomycin. Paediatria Japonica 65: 394–399.

5. MaltbyR, Leatham-JensenMP, GibsonT, CohenPS, ConwayT (2013) Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine. PLoS ONE 8: e53957 doi:10.1371/journal.pone.0053957

6. DeriuE, LiuJZ, PezeshkiM, EdwardsRA, OchoaRJ, et al. (2013) Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14: 26–37.

7. StecherB, HardtWD (2008) The role of microbiota in infectious disease. Trends Microbiol 16: 107–114.

8. NgKM, FerreyraJA, HigginbottomSK, LynchJB, KashyapPC, et al. (2013) Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502: 96–99.

9. SpeesAM, WangdiT, LopezCA, KingsburyDD, XavierMN, et al. (2013) Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. mBio 4: e00430–13.

10. FischbachMA, SonnenburgJL (2011) Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe 10: 336–347.

11. VeigaP, GalliniCA, BealC, MichaudM, DelaneyML, et al. (2010) Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A 107: 18132–18137.

12. DonohoeDR, WaliA, BrylawskiBP, BultmanSJ (2012) Microbial regulation of glucose metabolism and cell-cycle progression in mammalian colonocytes. PLoS ONE 7: e46589 doi:10.1371/journal.pone.0046589

13. NilssonNE, KotarskyK, OwmanC, OldeB (2003) Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids. Biochem Biophys Res Commun 303: 1047–1052.

14. MazmanianSK, RoundJL, KasperDL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453: 620–625.

15. RoundJL, LeeSM, LiJ, TranG, JabriB, et al. (2011) The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332: 974–977.

16. SmithPM, HowittMR, PanikovN, MichaudM, GalliniCA, et al. (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341: 569–573.

17. AtarashiK, TanoueT, ShimaT, ImaokaA, KuwaharaT, et al. (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337–341.

18. SekirovI, TamNM, JogovaM, RobertsonML, LiY, et al. (2008) Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 76: 4726–4736.

19. LuppC, RobertsonML, WickhamME, SekirovI, ChampionOL, et al. (2007) Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2: 119–129.

20. StecherB, RobbianiR, WalkerAW, WestendorfAM, BarthelM, et al. (2007) Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5: e244 doi:10.1371/journal.pbio.0050244

21. BarmanM, UnoldD, ShifleyK, AmirE, HungK, et al. (2008) Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 76: 907–915.

22. FrankDN, St AmandAL, FeldmanRA, BoedekerEC, HarpazN, et al. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780–13785.

23. Vujkovic-CvijinI, DunhamRM, IwaiS, MaherMC, AlbrightRG, et al. (2013) Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 5: 193ra191.

24. NormannE, FahlenA, EngstrandL, LiljaHE (2013) Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta paediatrica 102: 129–136.

25. WinterSE, ThiennimitrP, WinterMG, ButlerBP, HusebyDL, et al. (2010) Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426–429.

26. WinterSE, LopezCA, BäumlerAJ (2013) The dynamics of gut-associated microbial communities during inflammation. EMBO Rep 14: 319–327.

27. WinterSE, WinterMG, XavierMN, ThiennimitrP, PoonV, et al. (2013) Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339: 708–711.

28. LopezCA, WinterSE, Rivera-ChavezF, XavierMN, PoonV, et al. (2012) Phage-mediated acquisition of a type III secreted effector protein boosts growth of Salmonella by nitrate respiration. mBio 3: e00143–12.

29. ThiennimitrP, WinterSE, WinterMG, XavierMN, TolstikovV, et al. (2011) Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci U S A 108: 17480–17485.

30. WlodarskaM, WillingB, KeeneyKM, MenendezA, BergstromKS, et al. (2011) Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun 79: 1536–1545.

31. KopecnyJ, SimunekJ (2002) Cellulolytic bacteria in human gut and irritable bowel syndrome. Acta Veterinaria Brno 71: 421–427.

32. TreemWR, AhsanN, KastoffG, HyamsJS (1996) Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 23: 280–286.

33. MattoJ, MaunukselaL, KajanderK, PalvaA, KorpelaR, et al. (2005) Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome–a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43: 213–222.

34. Krogius-KurikkaL, LyraA, MalinenE, AarnikunnasJ, TuimalaJ, et al. (2009) Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 9: 95.

35. SaulnierDM, RiehleK, MistrettaTA, DiazMA, MandalD, et al. (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141: 1782–1791.

36. KerckhoffsAP, Ben-AmorK, SamsomM, van der RestME, de VogelJ, et al. (2011) Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol 60: 236–245.

37. CarrollIM, Ringel-KulkaT, SiddleJP, RingelY (2012) Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 24: 521–530, e248.